The Fund aims to achieve an income return, together with long-term capital growth.
Name | % Net Assets |
---|---|
GlaxoSmithKline PLC | 4.0% |
Diageo PLC | 3.6% |
Babcock International Group PLC | 3.2% |
Cable & Wireless PLC | 2.8% |
Smith & Nephew PLC | 2.8% |
Unilever PLC | 2.5% |
Melrose PLC | 2.4% |
VT Group PLC | 2.2% |
Chemring Group PLC | 2.2% |
Reed Elsevier PLC | 2.1% |
Key | % Net Assets |
---|---|
GlaxoSmithKline PLC | 4.0% |
Diageo PLC | 3.6% |
Babcock International Group PLC | 3.2% |
Cable & Wireless PLC | 2.8% |
Other | 86.4% |
Date | 02-Mar-2022 |
---|---|
NAV | 459.40p |
Currency | GBP |
Change | -8.70p |
% | -1.86% |
YTD change | 459.40p |
YTD % | n/a |
Fund Inception | 03/11/1989 |
---|---|
Fund Manager | Julie Dean |
TER | 0.96 (30-Apr-2011) |
Minimum Investment | |
---|---|
Initial | £1000000 |
Additional | £500,000 |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.12 |
You are here: research